Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals

Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals

US Patent 9834527 · Granted Dec 5, 2017

Estimated economic value: $11,040,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymer nanoparticle compositions for in vivo expression of polypeptides2025
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020
Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic ac2020
Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic ac2020
Exendin-4 derivatives as dual GLP1/glucagon agonists2020
Exendin-4 derivatives as dual GLP1/glucagon agonists2020